Trypanosoma cruzi: in vitro activity of Epoxy-α-Lap, a derivative of α-lapachone, on trypomastigote and amastigote forms

Experimental Parasitology

Volumn 122, Issue 2, 2009, Pages 91-96

  Bourguignon, S C ^a   Castro, H C ^a   Santos, D O ^a,b   Alves, C R ^b   Ferreira, V F ^a   Gama, I L ^a   Silva, F C ^a   Seguins, W S ^b   Pinho, R T ^b  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Lapachone; Epoxy Lap; Trypanocidal effect; Trypanosoma cruzi

Indexed keywords

ANTITRYPANOSOMAL AGENT; EPOXIDE; EPOXY ALPHA LAP; UNCLASSIFIED DRUG;

AMASTIGOTE; ANIMAL CELL; ANTIPROTOZOAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CHAGAS DISEASE; DRUG INHIBITION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; VERO CELL; VIROTHERAPY;

ANIMALS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOXY COMPOUNDS; FIBROBLASTS; HUMANS; LIFE CYCLE STAGES; MACROPHAGES; NAPHTHOQUINONES; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI; VERO CELLS;

TRYPANOSOMA CRUZI;

EID: 67349239895     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2009.03.002     Document Type: Article

References (31)

1. Andrade V., Andrade S.G., Netto Banal M., Pones A.L., and Castro R. Evaluation of the behavior of different strains of Trypanosoma cruzi in infections of 6 inbred strains of mice. Revista da Sociedade Brasileira de Medicina Tropical 18 (1985) 143-154
2. Bogdan C., Gessner A., Solbach W., and Rollinghoff M. Invasion, control and persistence of leishmania parasites. Current Opinion in Immunology 8 (1996) 517-525
3. Bourguignon S.C., Santos D.O., Gonzalez M.S., and Souto-Padrón T. Biological aspects of the Trypanosoma cruzi (Dm28c clone) intermediate form, between epimastigote and trypomastigote, obtained in modified Liver Infusion Tryptose (LIT) medium. Acta Tropica 98 (2006) 103-109
4. Brener Z. Biology of Trypanosoma cruzi. Annual Review of Microbiology 27 (1973) 343-382
5. Brener Z., and Andrade Z. Trypanosoma cruzi e Doença de Chagas (1979), Guanabara Koogan, Rio de Janeiro
6. Caldas S., Santos F.M., Lana M.D., Diniz L.F., Machado-Coelho G.L., Veloso V.M., and Bahia M.T. Trypanosoma cruzi: acute and long-term infection in the vertebrate host can modify the response to benznidazole. Experimental Parasitology 118 (2008) 315-323
7. Camandaroba E.L., Reis E.A., Gonçalves M.S., Reis M.G., and Andrade S.G. Trypanosoma cruzi: susceptibility to chemotherapy with benznidazole of clones isolated from the highly resistant Colombian strain. Revista da Sociedade Brasileira de Medicina Tropical 36 (2003) 201-209
8. Carneiro M., Romanha A.J., and Chiari E. Biological characterization of Trypanosoma cruzi strains from different zymodemes and schizodemes. Memorias do Instituto Oswaldo Cruz 86 (1991) 387-393
9. Carvalho-Moreira C.J., Spata M.C., Coura J.R., Garcia E.S., Azambuja P., Gonzalez M.S., and Mello C.B. In vivo and in vitro metacyclogenesis tests of two strains of Trypanosoma cruzi in the triatomine vectors Triatoma pseudomaculata and Rhodnius neglectus: short/long-term and comparative study. Experimental Parasitology 103 (2003) 102-111
10. Cazzulo J.J. Proteinases of Trypanosoma cruzi: potential targets for the chemotherapy of Chagas disease. Current Topics in Medicinal Chemistry 2 (2002) 1257-1267
11. Chang K.P. Leishmania infection of human skin fibroblasts in vitro: absence of phagolysosomal fusion after induced phagocytosis of promastigotes, and their intracellular transformation. American Journal Tropical Medicine and Hygiene 27 (1978) 1084-1096
12. De Moura K.C.G., Emery F.S., Neves-Pinto C., Pinto M.C.F.R., Dantas A.P., Salomão K., de Castro S.L., and Pinto A.V. Trypanocidal activity of isolated naphthoquinones from Tabebuia and some heterocyclic derivatives: a review from an interdisciplinary study. Journal of Brazilian Chemical Society 12 (2001) 325-338
13. De Souza W. Cell biology of Trypanosoma cruzi. International Review of Cytology 86 (1984) 197-283
14. Dias J.C., Silveira A.C., and Schofield C.J. The impact of Chagas disease control in Latin America: a review. Memorias do Instituto Oswaldo Cruz 97 (2002) 603-612
15. Dias L.R., Santos M.B., Albuquerque S., Castro H.C., de Souza A.M., Freitas A.C., DiVaio M.A., Cabral L.M., and Rodrigues C.R. Synthesis, in vitro evaluation, and SAR studies of a potential antichagasic 1H pyrazolo[3,4.b]pyridine series. Bioorganics Medicinal Chemistry 15 (2007) 211-219
16. Dos Santos E.V., Carneiro J.W., and Ferreira V.F. Quantitative structure-activity relationship in aziridinyl 1,4-naphthoquinone antimalarials: study of theoretical correlations by the PM3 method. Bioorganics Medicinal Chemistry 12 (2004) 87-93
17. Ferreira V.F., Jorqueira A., Souza A.M., Da Silva M.N., De Souza M.C., Gouvea R.M., Rodrigues C.R., Pinto A.V., Castro H.C., Santos D.O., Araujo H.P., and Bourguignon S.C. Trypanocidal agents with low cytotoxicity to mammalian cell line: a comparison of the theoretical and biological features of lapachone derivatives. Bioorganics Medicinal Chemistry 14 (2006) 5459-5466
18. Filardi L.S., and Brener Z. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used in Chagas' disease. Transactions of Royal Society of Tropical Medicine and Hygiene 81 (1987) 755-759
19. Hotez P.J., Remme J.H., Buss P., Alleyne G., Morel C., and Breman J.G. Combating tropical infectious diseases: report of the Disease Control Priorities in Developing Countries Project. Clinical Infeccion Diseases 38 (2004) 871-878
20. Jorqueira A., Gouvea R.M., Ferreira V.F., Da Silva M.N., De Souza M.C., Zuma A.A., Cavalcanti D.F., Araujo H.P., Santos D.O., and Bourguignon S.C. Oxyrane derivative of alpha-lapachone is potent growth inhibitor of Trypanosoma cruzi epimastigote forms. Parasitology Research 99 (2006) 429-433
21. Kollien A.H., and Schaub G.A. The development of Trypanosoma cruzi in triatominae. Parasitology Today 16 (2000) 381-387
22. Menna-Barreto R.F., Henriques-Pons A., Pinto A.V., Morgado-Diaz J.A., Soares M.J., and De Castro S.L. Effect of a beta-lapachone derived naphthoimidazole on Trypanosoma cruzi: identification of target organelles. Journal of Antimicrobial Chemotherapy 56 (2005) 1034-1041
23. Moll C., Peris P., Moreno A., Muñoz J., and Guañabens N. Severe invalidating pain syndrome associated with benznidazole therapy for Chagas' disease. Clinical Rheumatology 27 (2008) 269-270
24. Neves-Pinto C., Malta V.R., Pinto Mdo C., Santos R.H., de Castro S.L., and Pinto A.V. A trypanocidal phenazine derived from beta-lapachone. Journal of Medicinal Chemistry 45 (2002) 2112-2115
25. Pardee A.B., Li Y.Z., and Li C.J. Cancer therapy with beta-lapachone. Current Cancer Drug Targets 2 (2002) 227-242
26. Pinho R.T., Vannier-Santos M.A., Alves C.R., Marino A.P., Castello Branco L.R., and Lannes-Vieira J. Effect of Trypanosoma cruzi released antigens binding to non-infected cells on anti-parasite antibody recognition and expression of extracellular matrix components. Acta Tropica 83 2 (2002) 103-115
27. Santos D.O., Bourguignon S.C., Castro H.C., Silva J.S., Franco L.S., Hespanhol R., Soares M.J., and Corte-Real S. Infection of mouse dermal fibroblasts by the monoxenous trypanosomatid protozoa Crithidia deanei and Herpetomonas roitmani. The Journal of Eukaryotic Microbiology 51 (2004) 570-574
28. Saraiva V.B., Gibaldi D., Previato J.O., Mendonça-Previato L., Bozza M.T., Freire-de-Lima C.G., and Heise N. Proinflammatory and cytotoxic effects of hexadecylphosphocholine (Miltefosine) against drug-resistant strains of Trypanosoma cruzi. Antimicrobial Agents Chemotherapy 46 (2002) 3472-3477
29. Sosa-Estani S., Armenti A., Araujo G., Viotti R., Lococo B., Ruiz Vera B., Vigliano C., de Rissio A.M., and Segura E.L. Treatment of Chagas disease with benznidazole and thioctic acid. Medicina (B Aires) 64 (2004) 1-6
30. Urbina A.J. Chemotherapy of Chagas disease. Current Pharmaceutical Design 8 (2002) 287-295
31. Veloso V.M., Carneiro C.M., Toledo M.J., Lana M., Chiari E., Tafuri W.L., and Bahia M.T. Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains. Memorias do Instituto Oswaldo Cruz 96 (2001) 1005-1011